Can-Fite BioPharma Ltd.
CANF- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001536196
No open-market purchases or sales by Can-Fite BioPharma Ltd. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $149.1K in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Can-Fite BioPharma Ltd. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 8 | 11 | +3 |
| Shares | 477.6K | 627.8K | +150.2K (+31.5%) |
| Value | $1.06M | $1.62M | +$558.9K (+52.7%) |
New holders (5)
Institutions that held Can-Fite BioPharma Ltd. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 10,790 | $27.0K | 0.00% |
| Virtu Financial LLC | 10,417 | $27.0K | 0.00% |
| Activest Wealth Management | 200 | $516 | 0.00% |
| Advisor Group Holdings, Inc. | 185 | $477 | 0.00% |
| TD Waterhouse Canada Inc. | 20 | $52 | 0.00% |
Sold out (2)
Institutions that held Can-Fite BioPharma Ltd. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Citadel Advisors LLC | 14,171 | $31.5K |
| UBS Group AG | 2,172 | $4.82K |